256 Newsroom — Uganda's Digital News Infrastructure
Business

In autopsy of failed heart disease study, AstraZeneca raises broader questions about silencer drugs - STAT

Published by STAT By Andrew Joseph · 28 August 2026 at 18:27
Share
In autopsy of failed heart disease study, AstraZeneca raises broader questions about silencer drugs - STAT
Image · STAT

What the report says

AstraZeneca detailed the surprise failure of a closely watched heart disease trial, a study with ripple effects for a competitive billion-dollar market.

Read the full report at STAT →

Loading debate for this article…

Other publishers covering this story

No additional verified coverage is currently clustered with this report.

More stories by this journalist

Other publications from this journalist — open any story without leaving the article page.

No other published stories from this publisher yet.

Related reporting

How 256 Mall helps Ugandan businesses discover wholesale suppliers and request quotes online256 Mall AAYC chief Agaba mourns King Oyo as a friend, youth leadership iconWatchdog Uganda 256 Mall Export Hub puts Uganda’s export commodities into one clearer online marketplace256 Mall 256 Newsroom Khalifah’s 25-year labour bears Real Star fruit - Daily MonitorDaily Monitor How Permanent Secretary Ben Kumumanya’s Directives Are Reshaping Uganda’s Anti-Corruption Battle in Local GovernmentWatchdog Uganda Beb Wine Bags 2026 People’s Choice AwardDokolo Post